CA1003833A - Pyridazine derivatives - Google Patents

Pyridazine derivatives

Info

Publication number
CA1003833A
CA1003833A CA144,468A CA144468A CA1003833A CA 1003833 A CA1003833 A CA 1003833A CA 144468 A CA144468 A CA 144468A CA 1003833 A CA1003833 A CA 1003833A
Authority
CA
Canada
Prior art keywords
pyridazine derivatives
pyridazine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA144,468A
Other languages
English (en)
Other versions
CA144468S (fr
Inventor
Henri Laborit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1003833A publication Critical patent/CA1003833A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA144,468A 1971-06-18 1972-06-12 Pyridazine derivatives Expired CA1003833A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2873771 1971-06-18
FR7219096A FR2141697B1 (fr) 1971-06-18 1972-05-29

Publications (1)

Publication Number Publication Date
CA1003833A true CA1003833A (en) 1977-01-18

Family

ID=26217112

Family Applications (1)

Application Number Title Priority Date Filing Date
CA144,468A Expired CA1003833A (en) 1971-06-18 1972-06-12 Pyridazine derivatives

Country Status (13)

Country Link
US (1) US4169158A (fr)
JP (1) JPS5550943B1 (fr)
AR (1) AR192370A1 (fr)
AU (1) AU472247B2 (fr)
BE (1) BE784727A (fr)
CA (1) CA1003833A (fr)
CH (1) CH546769A (fr)
DE (1) DE2229215C2 (fr)
ES (1) ES403998A1 (fr)
FR (1) FR2141697B1 (fr)
GB (1) GB1345880A (fr)
NL (1) NL177893C (fr)
SE (1) SE392899B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2511366A1 (fr) * 1981-08-11 1983-02-18 Sanofi Sa Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2539742B1 (fr) * 1983-01-24 1986-09-05 Sanofi Sa Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central
FR2539739B1 (fr) * 1983-01-24 1985-11-22 Sanofi Sa Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant
FR2540115B1 (fr) * 1983-01-28 1985-06-07 Sanofi Sa Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions
FR2555178B1 (fr) * 1983-11-18 1986-04-18 Sanofi Sa Derives cyanes de la pyridazine ayant une action psychotrope, leur mode de preparation et les medicaments en contenant
FR2625201B1 (fr) * 1987-12-24 1990-06-15 Sanofi Sa Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant
FR2642757B1 (fr) * 1989-02-07 1991-05-24 Sanofi Sa Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant
PT93060B (pt) 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
FR2642754B1 (fr) * 1989-02-07 1991-05-24 Sanofi Sa Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US20030176437A1 (en) 2001-08-31 2003-09-18 D.M. Watterson Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
CA2589102C (fr) 2004-11-02 2013-08-13 Northwestern University Composes de pyridazine et methodes d'utilisation des composes pour traiter les maladies inflammatoires
EP2592075B1 (fr) 2004-11-02 2015-04-29 Northwestern University Composés de pyridazine pour le traitement des maladies inflammatoires
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
US8501739B2 (en) * 2005-07-04 2013-08-06 High Point Pharmaceuticals, Llc Medicaments
US20090325973A1 (en) * 2006-04-28 2009-12-31 Watterson D Martin Formulations containing pyridazine compounds
EP2015751A2 (fr) * 2006-04-28 2009-01-21 Northwestern University Sels de composés de pyridazine
EP2015750A2 (fr) 2006-04-28 2009-01-21 Northwestern University Compositions et traitements utilisant des pyridazines et des inhibiteurs de cholinestérase
JP2009537596A (ja) 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー ６−（４−シクロプロピルピペリジン−１−イル）−２’−メチル−［３，４’］−ビピリジン及びその医薬としての使用
KR20090040259A (ko) 2006-05-29 2009-04-23 하이 포인트 파마슈티칼스, 엘엘씨 3-(1,3-벤조디옥솔-5-일)-6-(4-시클로프로필피페라진-1-일)-피리다진, 그것의 염과 용매화합물 및 그것의 히스타민 ｈ3 수용체 안타고니스트로서의 용도
EP2014656A3 (fr) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC Nouveaux antagonistes d'hétéocycliques h3
WO2009128057A2 (fr) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Produits psycho-pharmaceutiques
EP2560488B1 (fr) 2010-04-23 2015-10-28 Cytokinetics, Inc. Aminopyridines et aminotriazines, leurs compositions et leurs procédés d'utilisation
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) * 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
CN112041679A (zh) 2018-01-23 2020-12-04 古斯塔夫·鲁西研究所 米那普利用于降低肿瘤生长的用途

Also Published As

Publication number Publication date
SE392899B (sv) 1977-04-25
JPS5550943B1 (fr) 1980-12-20
NL177893C (nl) 1985-12-16
NL177893B (nl) 1985-07-16
US4169158A (en) 1979-09-25
ES403998A1 (es) 1975-06-01
AU472247B2 (en) 1973-12-20
FR2141697A1 (fr) 1973-01-26
FR2141697B1 (fr) 1976-09-17
GB1345880A (en) 1974-02-06
AR192370A1 (es) 1973-02-14
AU4350072A (en) 1973-12-20
CH546769A (fr) 1974-03-15
DE2229215A1 (de) 1973-01-25
NL7208355A (fr) 1972-12-20
BE784727A (fr) 1972-10-02
DE2229215C2 (de) 1984-09-06

Similar Documents

Publication Publication Date Title
CA1003833A (en) Pyridazine derivatives
AU468250B2 (en) 3-nitropyrazole derivatives
CA943542A (en) Aminopyridazine derivatives
AU462723B2 (en) 2-nitro-5-imidazolyaldehyde derivatives
AU461957B2 (en) Lumilysergol derivatives
CA1017335A (en) Triazolyl-ethenyl-phenylene derivatives
AU463679B2 (en) Dibenzocycloheptadioxolan derivatives
AU470552B2 (en) Aminocephalosporin derivatives
AU472069B2 (en) Dibenzoxirenazepine derivatives
CA867769A (en) Fluoracylamino-trichloromethyl-methane derivatives
CA869544A (en) Thieno-benzothiazine derivatives
CA880321A (en) Tropanol derivatives
CA872254A (en) Indenopyridine derivatives
CA872252A (en) 4-substituted-benzocyclohepta-imidazole derivatives
CA871723A (en) Pyridyl-2-imidazolone derivatives
CA871716A (en) Norscopolamine derivatives
CA874996A (en) Diaryloxalamide derivatives
CA868361A (en) Thieno-benzothiazine derivatives
CA879103A (en) 3-amino-propoxy-indole derivatives
CA866804A (en) Spiro-azatetramethylene derivatives
CA863950A (en) Thienobenzothiazephine derivatives
CA863356A (en) Indenopyridine derivatives
CA862773A (en) N-phenylsuccinimide derivatives
CA862754A (en) Benzothiazepin-4-one derivatives
CA879692A (en) Benzazocine derivatives